Hydrogen Therapy Shows Promise for Stroke Recovery and Brain Protection

Authors
Journal
Experimental & Molecular Medicine
Year
DOI
10.1038/s12276-026-01733-z
Study Type
clinical
Peer Reviewed
Yes
Country
China
Health Condition
Intracerebral Hemorrhage
Body System
Nervous System

TL;DR

Scientists have figured out lots of new ways to treat a deadly type of stroke called brain bleeding, using everything from special drugs to exercise and physical therapy—and the best results happen when doctors combine several treatments tailored to each patient instead of just using one approach.

Key Finding

Treatment approaches for spontaneous intracerebral hemorrhage have evolved from single interventions to multimodal strategies combining pharmacological treatments (including hydrogen therapy), rehabilitation, and traditional medicine approaches.

Summary

This is a review article that examines how treatments for spontaneous intracerebral hemorrhage (ICH)—a type of stroke caused by bleeding in the brain—have changed over the past 60 years. The authors discuss various approaches including medications, rehabilitation programs, stem cell therapies, and hydrogen therapy, and note that modern treatment increasingly combines multiple strategies to reduce brain damage and improve recovery. The review emphasizes that future success will depend on personalizing treatments to individual patients and optimizing when and how medicines are given.

Practical Takeaway

This is a review article summarizing existing knowledge rather than reporting new research findings. While it mentions hydrogen therapy as an emerging approach for reducing oxidative stress and inflammation in ICH, no new evidence is presented here. Anyone interested in hydrogen water's potential role in stroke recovery should note that this review does not provide new clinical data—further human studies are needed to establish whether hydrogen therapy is actually beneficial for ICH patients.

Abstract (excerpt)

Spontaneous intracerebral hemorrhage (ICH), especially hypertensive basal ganglia hemorrhage, is a severe, often fatal stroke subtype with high morbidity and mortality. This historical review traces therapeutic progress from the 1960s to the present, emphasizing rehabilitation, peripheral-central…

Read the full abstract via DOI